Breakthrough uses directed evolution to develop versatile tool for medicine and research, overcoming natural limits of DNA-copying enzymes.

A Boston startup gains FDA approval to begin the first clinical trial using cellular reprogramming to treat eye disease, with potential implications for reversing aspects of aging.

A self-replicating synthetic cell has moved artificial life from theory to reality, opening a new chapter in synthetic biology and origin-of-life research.

MIT scientists have released a new open source AI model to predict protein structure with a performance similar to AlphaFold3.

MIT's DIAL system offers precise, adjustable control over protein expression in synthetic gene circuits to enhance uniform cell reprogramming and enable tailored therapies.

Researchers design proteins that respond to multiple body signals for targeted treatments, potentially reducing side effects in diseases like cancer.

The oncodarwinian hypothesis proposes that cancer may function as a self-replicating immune process that AIand three-dimensional printing could help reprogram for better control.

A new tool from Google cracks a decade-long puzzle about antibiotic-resistant germs, surprising scientists with fast and fresh ideas.

This synthetic biology system enables rapid development of proteins with improved functions, offering breakthroughs in creating treatments for diseases like cancer and neurodegeneration by speeding up lab-based evolution.

New technology creates tiny blood vessels to study drug effects and organ interactions